Nanox Imaging to Announce Q2 2026 Financial Results and Business Update on September 9

Nanox Imaging Ltd. (NASDAQ: NNOX), a company focused on transforming preventive healthcare through innovative medical imaging technology, has announced it will release its financial results for the quarter ended June 30, 2026, before market open on September 9, 2026. The announcement was made via a press release, which also detailed that CEO and Acting Chairman Erez Meltzer and CFO Guy Nathanzon will host a conference call at 8:30 a.m. ET to discuss the results and provide a business update. A live webcast will be accessible through the Investor Relations section of the Nanox website.

This upcoming report is significant for investors and the healthcare industry as it will provide a glimpse into Nanox's operational and financial performance during a period of strategic expansion. The company has been working to commercialize its integrated medical imaging and healthcare services platform, which aims to make diagnostic imaging more accessible and affordable, particularly in non-traditional settings.

Nanox's ecosystem includes several key components designed to streamline the imaging workflow from scan to interpretation. The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis system intended for ease of use and scalability. Nanox.AI offers a suite of AI-based algorithms that enhance the interpretation of routine CT imaging to identify early signs of chronic diseases. Nanox.CLOUD provides a secure cloud platform for data management and advanced analytics. Additionally, Nanox.MARKETPLACE and USARAD Holdings deliver remote radiology and cardiology expertise, while Nanox Health IT combines healthcare IT expertise with technology partners to offer RIS, PACS, AI, dictation, and secure infrastructure solutions.

The company's vision is to expand the reach of medical imaging beyond traditional hospital settings, leveraging proprietary digital X-ray technology and AI-driven analytics to improve clinical efficiency and patient outcomes. By integrating these technologies, Nanox seeks to lower barriers to adoption and improve utilization of imaging services, ultimately advancing preventive care worldwide.

Investors and stakeholders will be keen to hear management's commentary on the company's progress, including any updates on regulatory approvals, commercial partnerships, and revenue generation. The conference call will provide an opportunity for analysts to ask questions and gain deeper insights into Nanox's strategic direction.

For more information about Nanox, visit the company's newsroom at http://ibn.fm/NNOX.